Abstract:Marine actinomycetes are an important source of antibiotics, but many of them are yet to be explored in terms of taxonomy, ecology, and functional activity. In this study, two marine actinobacterial strains, designated SCSIO 64649 T and SCSIO 03032, were isolated, and the potential for bioactive natural product discovery was evaluated based on genome mining, compound detection, and antimicrobial activity. Phylogenetic analysis of the 16S rRNA gene sequences showed that strain SCSIO 64649 T formed a single clade with SCSIO 03032 (similarity 99.5%) and sister clades with the species Streptomyces specialis DSM 41924 T (97.1%) and Streptomyces manganisoli MK44 T (96.8%). The whole genome size of strain SCSIO 64649 T was 6.63 Mbp with a 73.6% G + C content. The average nucleotide identity and digital DNA–DNA hybridization between strain SCSIO 64649 T and its closest related species were well below the thresholds recommended for species delineation. Therefore, according to the results of polyphasic taxonomy analysis, the strains SCSIO 64649 T and SCSIO 03032 are proposed to represent a novel species named Streptomyces marincola sp. nov. Furthermore, strains SCSIO 64649 T and 03032 encode 37 putative biosynthetic gene clusters, and in silico analysis revealed that this new species has a high potential to produce unique natural products, such as a novel polyene polyketide compounds, two mayamycin analogs, and a series of post-translationally modified peptides. In addition, other important bioactive natural products, such as heronamide F, piericidin A1, and spiroindimicin A, were also detected in strain SCSIO 64649 T . Finally, this new species’ metabolic crude extract showed a strong antimicrobial activity. Thanks to the integration of all these analyses, this study demonstrates that the novel species Streptomyces marincola has a unique and novel secondary metabolite biosynthetic potential that not only is beneficial to possible marine hosts but that could also be exploited for industrial applications.

Marine mudflat actinomycetes as a novel natural products source

Marine actinomycetes as a source of novel secondary metabolites

Marine Actinomycetes, New Sources of Biotechnological Products

Marine Rare Actinomycetes: A Promising Source of Structurally Diverse and Unique Novel Natural Products

Natural Products from Actinomycetes Associated with Marine Organisms

Marine Actinomycetes the Past, the Present and the Future

Marine Actinomycetes: An Endless Source of Potentially Therapeutic Novel Secondary Metabolites and Other Bioactive Compounds

Marine actinomycetes as an emerging resource for the drug development pipelines

Bioprospecting of Novel and Bioactive Compounds from Marine Actinomycetes Isolated from South China Sea Sediments

Streptomyces marincola sp. nov., a Novel Marine Actinomycete, and Its Biosynthetic Potential of Bioactive Natural Products

New natural products identified by combined genomics-metabolomics profiling of marine Streptomyces sp. MP131-18

Investigation on taxonomy, secondary metabolites and antibacterial activity of Streptomyces sediminicola sp. nov., a novel marine sediment-derived Actinobacteria

Study of marine microorganism metabolites: new resources for bioactive natural products

Major Source of Marine Actinobacteria and Its Biomedical Application

Marine Sediment-Derived Streptomyces Bacteria from British Columbia, Canada Are a Promising Microbiota Resource for the Discovery of Antimicrobial Natural Products

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Natural Products from Actinobacteria for Drug Discovery

Advances in Antimicrobial Natural Products Derived from Marine Actinomycetes

Pharmaceutically active secondary metabolites of marine actinobacteria

SECONDARY METABOLITES PRODUCED BY MARINE ACTINOMYCETE STREPTOMYCES SP. G246